Detoxification of amyloid β fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer's model
- 20 January 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (15) , 2576-2579
Abstract
Curcumin derivatives B and N developed as disaggregation agents of amyloid β (Aβ) fibrils significantly rescued locomotion dysfunction in an Aβ-expressing Drosophila model of Alzheimer's disease.Keywords
Funding Information
- Niigata University (2021-21013)
- Ministry of Education, Culture, Sports, Science and Technology (19K22592, 20H04699, 21H02837)
This publication has 34 references indexed in Scilit:
- Immunotherapy for Alzheimer’s disease: hoops and hurdlesMolecular Neurodegeneration, 2013
- Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug DiscoveryPharmacological Reviews, 2011
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicityProceedings of the National Academy of Sciences, 2010
- The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compoundsThe FEBS Journal, 2009
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s diseaseNeuroscience, 2005
- A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogasterMolecular and Cellular Neuroscience, 2004
- Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila : A potential model for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2004
- β‐Amyloid peptide induces formation of actin stress fibers through p38 mitogen‐activated protein kinaseJournal of Neurochemistry, 2002
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984